Therapeutic: ivosidenib for cholangiocarcinoma
Cholangiocarcinoma is a rare and aggressive cancer of the bile ducts, occurring both within and outside the liver. Survival rates are poor, not least because the majority of patients will have advanced disease by the time they are diagnosed